English
Segment disclosures
Company overviewSTRATA SKIN SCIENCES, INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · CN · Dermatology Procedures Equipment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:CN;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 3355000 | USD | 20260326 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 130000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2623000 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1659000 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2493000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 4069000 | USD | 20260326 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1045000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 3165000 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1018000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2120000 | USD | 20250814 | Open filing evidence |
Operating Segments · CN · Dermatology Recurring Procedures
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:CN;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260326 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260326 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250814 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20250328 | Open filing evidence |
Operating Segments · KR · Dermatology Procedures Equipment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:KR;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 2055000 | USD | 20240328 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2828000 | USD | 20240328 | Open filing evidence |
Operating Segments · US · Dermatology Procedures Equipment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 1012000 | USD | 20260326 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 142000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 688000 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 397000 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 546000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1357000 | USD | 20260326 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 677000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1275000 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 458000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 598000 | USD | 20250814 | Open filing evidence |
Operating Segments · US · Dermatology Recurring Procedures
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 19572000 | USD | 20260326 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 5076000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 13987000 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 4663000 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 8911000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 19531000 | USD | 20260326 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 4893000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 14136000 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 4923000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 9243000 | USD | 20250814 | Open filing evidence |
Operating Segments · Geographic Distribution Other Foreign · Dermatology Procedures Equipment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 2955000 | USD | 20260326 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 939000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1511000 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 181000 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 572000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 4199000 | USD | 20260326 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 970000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2692000 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1336000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1722000 | USD | 20250814 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 3356000 | USD | 20240328 | Open filing evidence |
Operating Segments · Geographic Distribution Other Foreign · Dermatology Recurring Procedures
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 1906000 | USD | 20260326 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 470000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1405000 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 456000 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 935000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1640000 | USD | 20260326 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 488000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1280000 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 416000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 792000 | USD | 20250814 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 642000 | USD | 20240328 | Open filing evidence |
Operating Segments · Geographic Distribution Domestic · Dermatology Procedures Equipment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-06-30 | 1422000 | USD | 20240814 | Open filing evidence |
Operating Segments · Geographic Distribution Domestic · Dermatology Recurring Procedures
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 20215000 | USD | 20240328 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 4960000 | USD | 20241114 | Open filing evidence |
Operating Segments · Geographic Distribution Foreign · Dermatology Procedures Equipment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 1917000 | USD | 20240515 | Open filing evidence |
Operating Segments · Middle East · Dermatology Procedures Equipment
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:MiddleEastMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 1896000 | USD | 20260326 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 172000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1190000 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 307000 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1018000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2766000 | USD | 20260326 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 724000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1438000 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 284000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 714000 | USD | 20250814 | Open filing evidence |
Operating Segments · Middle East · Dermatology Recurring Procedures
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:MiddleEastMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260326 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260326 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250814 | Open filing evidence |
Operating Segments · CN · Dermatology Procedures Equipment
Consolidation Items · Geographic Distribution · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=country:CN;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 4556000 | USD | 20230331 | Open filing evidence |
Operating Segments · Geographic Distribution Domestic · Dermatology Procedures Equipment
Consolidation Items · Geographic Distribution · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-09-30 | 2301000 | USD | 20231114 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1422000 | USD | 20230809 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 547000 | USD | 20220810 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 695000 | USD | 20230515 | Open filing evidence |
Operating Segments · Geographic Distribution Domestic · Dermatology Recurring Procedures
Consolidation Items · Geographic Distribution · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-06-30 | 9866000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 4689000 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 9553000 | USD | 20220810 | Open filing evidence |
Operating Segments · Geographic Distribution Foreign · Dermatology Procedures Equipment
Consolidation Items · Geographic Distribution · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 1862000 | USD | 20230515 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 7249000 | USD | 20221109 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 4255000 | USD | 20220810 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 5467000 | USD | 20220321 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 890000 | USD | 20220511 | Open filing evidence |
Operating Segments · Geographic Distribution Foreign · Dermatology Recurring Procedures
Consolidation Items · Geographic Distribution · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-09-30 | 1103000 | USD | 20231114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 405000 | USD | 20220810 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 578000 | USD | 20220810 | Open filing evidence |
Operating Segments · Dermatology Imaging
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyImagingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 0 | USD | 20191030 | Open filing evidence |
Operating Segments · Dermatology Procedures Equipment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 9218000 | USD | 20260326 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1383000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 6012000 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2544000 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 4629000 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 2085000 | USD | 20250515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 12391000 | USD | 20260326 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 3416000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 8570000 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 3096000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 5154000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2058000 | USD | 20250515 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 3572000 | USD | 20231114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 8724000 | USD | 20231114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2794000 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 5152000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 2358000 | USD | 20240515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 13136000 | USD | 20230331 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 9063000 | USD | 20231114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 3523000 | USD | 20220810 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 5497000 | USD | 20230809 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 7449000 | USD | 20230331 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 2001000 | USD | 20211112 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 5079000 | USD | 20221109 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 1930000 | USD | 20210816 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 3078000 | USD | 20220810 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 1148000 | USD | 20210513 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 5681000 | USD | 20220321 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1778000 | USD | 20201110 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1234000 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 2263000 | USD | 20200812 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 1029000 | USD | 20200513 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 7873000 | USD | 20210325 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 1489000 | USD | 20191118 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 5546000 | USD | 20201110 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1886000 | USD | 20200812 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 4057000 | USD | 20191114 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 2171000 | USD | 20200513 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 8802000 | USD | 20191030 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 2336000 | USD | 20191118 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 6671000 | USD | 20181114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 2366000 | USD | 20191114 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 4334000 | USD | 20180814 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 8792000 | USD | 20191030 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 1751000 | USD | 20181114 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 5784000 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 2500000 | USD | 20180814 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 4041000 | USD | 20180814 | Open filing evidence |
Operating Segments · Dermatology Procedures Equipment · US
Consolidation Items · Statement Business Segments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:StatementGeographicalAxis=country:US| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 2813000 | USD | 20250328 | Open filing evidence |
Operating Segments · Dermatology Procedures Equipment · Geographic Distribution Other Foreign
Consolidation Items · Statement Business Segments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 6965000 | USD | 20250328 | Open filing evidence |
Operating Segments · Dermatology Procedures Equipment · Geographic Distribution Domestic
Consolidation Items · Statement Business Segments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 879000 | USD | 20241114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2301000 | USD | 20241114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 926000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 496000 | USD | 20240515 | Open filing evidence |
Operating Segments · Dermatology Procedures Equipment · Geographic Distribution Foreign
Consolidation Items · Statement Business Segments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-09-30 | 7295000 | USD | 20241114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1868000 | USD | 20240814 | Open filing evidence |
Operating Segments · Dermatology Procedures Equipment · Geographic Distribution Other Foreign
Consolidation Items · Statement Business Segments · Geographic Distribution
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:GeographicDistributionAxis=sskn:GeographicDistributionOtherForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 3356000 | USD | 20230331 | Open filing evidence |
Operating Segments · Dermatology Procedures Equipment · Geographic Distribution Domestic
Consolidation Items · Statement Business Segments · Geographic Distribution
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 572000 | USD | 20221109 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 336000 | USD | 20220810 | Open filing evidence |
Operating Segments · Dermatology Procedures Equipment · Geographic Distribution Foreign
Consolidation Items · Statement Business Segments · Geographic Distribution
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 2693000 | USD | 20231114 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 1594000 | USD | 20220810 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 2484000 | USD | 20220810 | Open filing evidence |
Operating Segments · Dermatology Recurring Procedures
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 21478000 | USD | 20260326 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 5546000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 15392000 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 5119000 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 9846000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 21171000 | USD | 20260326 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 5381000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 15416000 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 5339000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 10035000 | USD | 20250814 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 21530000 | USD | 20250328 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 5280000 | USD | 20231114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 15945000 | USD | 20241114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5456000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 10665000 | USD | 20240814 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 23025000 | USD | 20240328 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 5847000 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 16496000 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 10649000 | USD | 20220810 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 5067000 | USD | 20220511 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 22528000 | USD | 20230331 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 15841000 | USD | 20221109 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 5452000 | USD | 20220810 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 10131000 | USD | 20220810 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 4679000 | USD | 20220511 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 3835000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 12332000 | USD | 20211112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 2796000 | USD | 20200812 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 8497000 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 5701000 | USD | 20210513 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 23713000 | USD | 20200317 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 17142000 | USD | 20201110 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 5839000 | USD | 20200812 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 11151000 | USD | 20191114 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 5312000 | USD | 20191108 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 22954000 | USD | 20191030 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 17051000 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 5971000 | USD | 20180814 | Open filing evidence |
Operating Segments · Dermatology Recurring Procedures · CN
Consolidation Items · Statement Business Segments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:StatementGeographicalAxis=country:CN| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250328 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250515 | Open filing evidence |
Operating Segments · Dermatology Recurring Procedures · US
Consolidation Items · Statement Business Segments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:StatementGeographicalAxis=country:US| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 4248000 | USD | 20250515 | Open filing evidence |
Operating Segments · Dermatology Recurring Procedures · Geographic Distribution Other Foreign
Consolidation Items · Statement Business Segments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 479000 | USD | 20250515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 357000 | USD | 20240328 | Open filing evidence |
Operating Segments · Dermatology Recurring Procedures · Geographic Distribution Domestic
Consolidation Items · Statement Business Segments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 4923000 | USD | 20240814 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 4320000 | USD | 20240515 | Open filing evidence |
Operating Segments · Dermatology Recurring Procedures · Geographic Distribution Foreign
Consolidation Items · Statement Business Segments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 315000 | USD | 20240814 | Open filing evidence |
Operating Segments · Dermatology Recurring Procedures · CN
Consolidation Items · Statement Business Segments · Geographic Distribution
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=country:CN| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 195000 | USD | 20230331 | Open filing evidence |
Operating Segments · Dermatology Recurring Procedures · Geographic Distribution Domestic
Consolidation Items · Statement Business Segments · Geographic Distribution
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-09-30 | 15393000 | USD | 20231114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 5177000 | USD | 20230809 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 21215000 | USD | 20230331 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 5127000 | USD | 20220810 | Open filing evidence |
Operating Segments · Dermatology Recurring Procedures · Geographic Distribution Foreign
Consolidation Items · Statement Business Segments · Geographic Distribution
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 378000 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 918000 | USD | 20221109 | Open filing evidence |
CN · Operating Segments · Dermatology Procedures Equipment
Statement Geographical · Consolidation Items · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=country:CN;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 834000 | USD | 20250515 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 3340000 | USD | 20240328 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 4556000 | USD | 20240328 | Open filing evidence |
CN · Dermatology Procedures Equipment · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=country:CN;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 3340000 | USD | 20250328 | Open filing evidence |
CN · Dermatology Recurring Procedures · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=country:CN;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 0 | USD | 20250515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 195000 | USD | 20240328 | Open filing evidence |
KR · Dermatology Recurring Procedures · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=country:KR;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 888000 | USD | 20240328 | Open filing evidence |
US · Operating Segments · Dermatology Procedures Equipment
Statement Geographical · Consolidation Items · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=country:US;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 1357000 | USD | 20250328 | Open filing evidence |
US · Operating Segments · Dermatology Recurring Procedures
Statement Geographical · Consolidation Items · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=country:US;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 4320000 | USD | 20250515 | Open filing evidence |
US · Dermatology Procedures Equipment · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 149000 | USD | 20250515 | Open filing evidence |
US · Dermatology Recurring Procedures · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 20215000 | USD | 20250328 | Open filing evidence |
Geographic Distribution Other Foreign · Operating Segments · Dermatology Procedures Equipment
Statement Geographical · Consolidation Items · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 385000 | USD | 20250515 | Open filing evidence |
Geographic Distribution Other Foreign · Dermatology Procedures Equipment · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 5675000 | USD | 20250328 | Open filing evidence |
Geographic Distribution Other Foreign · Dermatology Recurring Procedures · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 1640000 | USD | 20250328 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1315000 | USD | 20250328 | Open filing evidence |
Geographic Distribution Domestic · Operating Segments · Dermatology Procedures Equipment
Statement Geographical · Consolidation Items · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 677000 | USD | 20241114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1275000 | USD | 20241114 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 141000 | USD | 20240515 | Open filing evidence |
Geographic Distribution Domestic · Operating Segments · Dermatology Recurring Procedures
Statement Geographical · Consolidation Items · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 4893000 | USD | 20241114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 14136000 | USD | 20241114 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 9243000 | USD | 20240814 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5141000 | USD | 20240814 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 21585000 | USD | 20240328 | Open filing evidence |
Geographic Distribution Domestic · Dermatology Recurring Procedures · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-09-30 | 14948000 | USD | 20241114 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 9988000 | USD | 20240814 | Open filing evidence |
Geographic Distribution Foreign · Operating Segments · Dermatology Procedures Equipment
Statement Geographical · Consolidation Items · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 2739000 | USD | 20241114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2638000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 3730000 | USD | 20240814 | Open filing evidence |
Geographic Distribution Foreign · Operating Segments · Dermatology Recurring Procedures
Statement Geographical · Consolidation Items · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-09-30 | 1280000 | USD | 20241114 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 376000 | USD | 20240515 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 320000 | USD | 20241114 | Open filing evidence |
Geographic Distribution Foreign · Dermatology Procedures Equipment · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-09-30 | 6423000 | USD | 20241114 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1862000 | USD | 20240515 | Open filing evidence |
Geographic Distribution Foreign · Dermatology Recurring Procedures · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 416000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 362000 | USD | 20240515 | Open filing evidence |
Middle East · Operating Segments · Dermatology Procedures Equipment
Statement Geographical · Consolidation Items · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=us-gaap:MiddleEastMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 711000 | USD | 20250515 | Open filing evidence |
Middle East · Operating Segments · Dermatology Recurring Procedures
Statement Geographical · Consolidation Items · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=us-gaap:MiddleEastMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250515 | Open filing evidence |
Middle East · Dermatology Procedures Equipment · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=us-gaap:MiddleEastMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 430000 | USD | 20250515 | Open filing evidence |
Middle East · Dermatology Recurring Procedures · Operating Segments
Statement Geographical · Statement Business Segments · Consolidation Items
Source dimensions
srt:StatementGeographicalAxis=us-gaap:MiddleEastMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 0 | USD | 20250515 | Open filing evidence |
Operating Segments · Dermatology Imaging
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyImagingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2015-07-01 – 2015-09-30 | 101000 | USD | 20151116 | Open filing evidence |
| 2015-01-01 – 2015-09-30 | 239000 | USD | 20151116 | Open filing evidence |
| 2014-01-01 – 2014-09-30 | 541000 | USD | 20151116 | Open filing evidence |
Operating Segments · Dermatology Procedures Equipment
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2015-01-01 – 2015-09-30 | 1638000 | USD | 20151116 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 0 | USD | 20151116 | Open filing evidence |
| 2014-01-01 – 2014-09-30 | 0 | USD | 20151116 | Open filing evidence |
Operating Segments · Dermatology Recurring Procedures
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2015-07-01 – 2015-09-30 | 7033000 | USD | 20151116 | Open filing evidence |
| 2015-01-01 – 2015-09-30 | 7138000 | USD | 20151116 | Open filing evidence |
| 2014-01-01 – 2014-09-30 | 0 | USD | 20151116 | Open filing evidence |
Operating Segments · Dermatology Imaging
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyImagingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-01-01 – 2017-12-31 | 17000 | USD | 20180402 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 9000 | USD | 20171114 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 8000 | USD | 20170811 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 4000 | USD | 20180515 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 134000 | USD | 20180402 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 12000 | USD | 20171114 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 126000 | USD | 20161114 | Open filing evidence |
| 2016-01-01 – 2016-06-30 | 114000 | USD | 20170811 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 102000 | USD | 20160516 | Open filing evidence |
| 2015-01-01 – 2015-12-31 | 288000 | USD | 20160315 | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 101000 | USD | 20161114 | Open filing evidence |
| 2015-01-01 – 2015-09-30 | 239000 | USD | 20161114 | Open filing evidence |
| 2015-01-01 – 2015-03-31 | 81000 | USD | 20160516 | Open filing evidence |
Operating Segments · Dermatology Procedures Equipment
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 1968000 | USD | 20180515 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 5784000 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 2496000 | USD | 20170811 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 1537000 | USD | 20180515 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 7065000 | USD | 20170313 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 1550000 | USD | 20171114 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 5174000 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 1634000 | USD | 20170811 | Open filing evidence |
| 2016-01-01 – 2016-06-30 | 3624000 | USD | 20160812 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 1990000 | USD | 20170515 | Open filing evidence |
| 2015-01-01 – 2015-06-30 | 449000 | USD | 20160812 | Open filing evidence |
| 2015-01-01 – 2015-03-31 | 0 | USD | 20160516 | Open filing evidence |
| 2014-01-01 – 2014-12-31 | 0 | USD | 20160315 | Open filing evidence |
Operating Segments · Dermatology Recurring Procedures
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-01-01 – 2017-12-31 | 22640000 | USD | 20180402 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 5720000 | USD | 20171114 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 17653000 | USD | 20171114 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 11933000 | USD | 20170811 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 5556000 | USD | 20180515 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 6205000 | USD | 20161114 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 17826000 | USD | 20161114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 6093000 | USD | 20170811 | Open filing evidence |
| 2016-01-01 – 2016-06-30 | 11621000 | USD | 20160812 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 5528000 | USD | 20160516 | Open filing evidence |
| 2015-01-01 – 2015-12-31 | 14616000 | USD | 20170313 | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 7033000 | USD | 20161114 | Open filing evidence |
| 2015-01-01 – 2015-09-30 | 7138000 | USD | 20161114 | Open filing evidence |
| 2015-01-01 – 2015-06-30 | 104000 | USD | 20160812 | Open filing evidence |
| 2014-01-01 – 2014-12-31 | 0 | USD | 20160315 | Open filing evidence |
CN · Dermatology Procedures Equipment · Operating Segments
Geographic Distribution · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:GeographicDistributionAxis=country:CN;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 931000 | USD | 20230331 | Open filing evidence |
KR · Dermatology Procedures Equipment · Operating Segments
Geographic Distribution · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:GeographicDistributionAxis=country:KR;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 2412000 | USD | 20230331 | Open filing evidence |
Geographic Distribution Other Foreign · Dermatology Procedures Equipment · Operating Segments
Geographic Distribution · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:GeographicDistributionAxis=sskn:GeographicDistributionOtherForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 2124000 | USD | 20230331 | Open filing evidence |
Geographic Distribution Other Foreign · Dermatology Recurring Procedures · Operating Segments
Geographic Distribution · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:GeographicDistributionAxis=sskn:GeographicDistributionOtherForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 357000 | USD | 20230331 | Open filing evidence |
Geographic Distribution Domestic · Operating Segments · Dermatology Procedures Equipment
Geographic Distribution · Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 572000 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1814000 | USD | 20221109 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1242000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 695000 | USD | 20220511 | Open filing evidence |
Geographic Distribution Domestic · Operating Segments · Dermatology Recurring Procedures
Geographic Distribution · Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 21215000 | USD | 20220321 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 14923000 | USD | 20221109 | Open filing evidence |
Geographic Distribution Domestic · Dermatology Procedures Equipment
Geographic Distribution · Statement Business Segments
Source dimensions
us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-09-30 | 1113000 | USD | 20211112 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 336000 | USD | 20210816 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 594000 | USD | 20210816 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 258000 | USD | 20210513 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 261000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 701000 | USD | 20211112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 125000 | USD | 20200812 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 440000 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 315000 | USD | 20210513 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1243000 | USD | 20210325 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 241000 | USD | 20201110 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 943000 | USD | 20191118 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 378000 | USD | 20200812 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 702000 | USD | 20200812 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 324000 | USD | 20200513 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 2026000 | USD | 20200317 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 366000 | USD | 20191118 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 1337000 | USD | 20191118 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 313000 | USD | 20191114 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 970000 | USD | 20191114 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 617000 | USD | 20181114 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 1959000 | USD | 20181114 | Open filing evidence |
Geographic Distribution Domestic · Dermatology Procedures Equipment · Operating Segments
Geographic Distribution · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 496000 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1982000 | USD | 20220321 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 519000 | USD | 20221109 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 594000 | USD | 20220810 | Open filing evidence |
Geographic Distribution Domestic · Dermatology Recurring Procedures
Geographic Distribution · Statement Business Segments
Source dimensions
us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-07-01 – 2021-09-30 | 5370000 | USD | 20211112 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 5127000 | USD | 20210816 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 9553000 | USD | 20210816 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 4426000 | USD | 20210513 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 3690000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 11957000 | USD | 20201110 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 2670000 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 8267000 | USD | 20200812 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 5597000 | USD | 20200513 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 23645000 | USD | 20210325 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 5991000 | USD | 20191118 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 17142000 | USD | 20191118 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 5839000 | USD | 20200812 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 11151000 | USD | 20191114 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 5312000 | USD | 20200513 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 21053000 | USD | 20191030 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 5393000 Restated | USD | 20191118 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 5022000 Restated | USD | 20191114 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 9665000 | USD | 20180814 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 22954000 | USD | 20191030 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 5525000 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 5971000 | USD | 20180814 | Open filing evidence |
Geographic Distribution Domestic · Dermatology Recurring Procedures · Operating Segments
Geographic Distribution · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 5177000 | USD | 20220810 | Open filing evidence |
Geographic Distribution Foreign · Operating Segments · Dermatology Procedures Equipment
Geographic Distribution · Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 2976000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1279000 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 3966000 | USD | 20221109 | Open filing evidence |
Geographic Distribution Foreign · Operating Segments · Dermatology Recurring Procedures
Geographic Distribution · Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-09-30 | 997000 | USD | 20231114 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 677000 | USD | 20230809 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 320000 | USD | 20221109 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 783000 | USD | 20230809 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1313000 | USD | 20220321 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 325000 | USD | 20220810 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 253000 | USD | 20220511 | Open filing evidence |
Geographic Distribution Foreign · Dermatology Procedures Equipment And Imaging
Geographic Distribution · Statement Business Segments
Source dimensions
us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentAndImagingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-01-01 – 2017-12-31 | 5271000 | USD | 20191030 | Open filing evidence |
Geographic Distribution Foreign · Dermatology Procedures Equipment
Geographic Distribution · Statement Business Segments
Source dimensions
us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-07-01 – 2021-09-30 | 1482000 | USD | 20211112 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 1594000 | USD | 20210816 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 890000 | USD | 20210513 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 1823000 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 714000 | USD | 20210513 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 4603000 | USD | 20201110 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 3355000 | USD | 20191114 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 1847000 | USD | 20200513 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 6776000 | USD | 20191030 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 1970000 | USD | 20181114 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 3364000 | USD | 20180814 | Open filing evidence |
Geographic Distribution Foreign · Dermatology Procedures Equipment · Operating Segments
Geographic Distribution · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 1868000 | USD | 20230809 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 2976000 | USD | 20220810 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 4255000 | USD | 20230809 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 1482000 | USD | 20221109 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 4725000 | USD | 20220321 | Open filing evidence |
Geographic Distribution Foreign · Dermatology Recurring Procedures
Geographic Distribution · Statement Business Segments
Source dimensions
us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-07-01 – 2021-09-30 | 340000 | USD | 20211112 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 918000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 375000 | USD | 20201110 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 126000 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 104000 | USD | 20210513 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 68000 | USD | 20210325 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 0 | USD | 20201110 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 0 | USD | 20201110 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 0 | USD | 20200812 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 0 | USD | 20200812 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 0 | USD | 20200513 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 0 | USD | 20200317 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 20191118 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 0 | USD | 20191118 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 0 | USD | 20191114 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 0 | USD | 20191114 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 0 | USD | 20191108 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 0 | USD | 20191030 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 0 | USD | 20181114 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 0 | USD | 20181114 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 0 | USD | 20180814 | Open filing evidence |
Geographic Distribution Foreign · Dermatology Recurring Procedures · Operating Segments
Geographic Distribution · Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 378000 | USD | 20220511 | Open filing evidence |
Dermatology Imaging · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyImagingMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-07-01 – 2014-09-30 | 218000 | USD | 20151116 | Open filing evidence |
Dermatology Procedures Equipment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-07-01 – 2014-09-30 | 0 | USD | 20151116 | Open filing evidence |
| 2014-01-01 – 2014-09-30 | 0 | USD | 20151116 | Open filing evidence |
Dermatology Procedures Equipment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyProceduresEquipmentMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2015-07-01 – 2015-09-30 | 1189000 | USD | 20151116 | Open filing evidence |
Dermatology Recurring Procedures
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-07-01 – 2014-09-30 | 0 | USD | 20151116 | Open filing evidence |
| 2014-01-01 – 2014-09-30 | 0 | USD | 20151116 | Open filing evidence |
Dermatology Recurring Procedures · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyRecurringProceduresMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-07-01 – 2014-09-30 | 0 | USD | 20151116 | Open filing evidence |
Dermatology Imaging · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyImagingMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-01-01 – 2017-12-31 | 17000 | USD | 20191030 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 9000 | USD | 20181114 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 17000 | USD | 20181114 | Open filing evidence |
Dermatology Imaging · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyImagingMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-01-01 – 2017-09-30 | 17000 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 4000 | USD | 20170811 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 4000 | USD | 20170515 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 134000 | USD | 20170313 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 126000 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 12000 | USD | 20170811 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 102000 | USD | 20170515 | Open filing evidence |
| 2015-01-01 – 2015-12-31 | 288000 | USD | 20170313 | Open filing evidence |
| 2015-04-01 – 2015-06-30 | 58000 | USD | 20160812 | Open filing evidence |
| 2015-01-01 – 2015-06-30 | 139000 | USD | 20160812 | Open filing evidence |
| 2014-01-01 – 2014-12-31 | 915000 | USD | 20160315 | Open filing evidence |
Dermatology Procedures Equipment And Imaging
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentAndImagingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-01-01 – 2017-12-31 | 8809000 | USD | 20191030 | Open filing evidence |
Dermatology Procedures Equipment And Imaging · Geographic Distribution Domestic
Statement Business Segments · Geographic Distribution
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentAndImagingMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-01-01 – 2017-12-31 | 3538000 | USD | 20191030 | Open filing evidence |
Dermatology Procedures Equipment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 9218000 | USD | 20260326 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 12391000 | USD | 20260326 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 11828000 | USD | 20250328 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 13136000 | USD | 20240328 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 7449000 | USD | 20230331 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 2001000 | USD | 20211112 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 5079000 | USD | 20211112 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 1930000 | USD | 20210816 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 3078000 | USD | 20210816 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 1148000 | USD | 20210513 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 5681000 | USD | 20220321 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1778000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 4041000 | USD | 20211112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1234000 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 2263000 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 1029000 | USD | 20210513 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 7837000 Restated | USD | 20210325 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 1489000 | USD | 20201110 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 5546000 | USD | 20201110 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1886000 | USD | 20200812 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 4057000 | USD | 20200812 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 2171000 | USD | 20200513 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 8802000 | USD | 20200317 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 2366000 | USD | 20191118 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 6670000 Restated | USD | 20191118 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 2366000 | USD | 20191114 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 4334000 | USD | 20191114 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 1968000 | USD | 20191108 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 1760000 | USD | 20181114 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 5801000 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 2500000 | USD | 20180814 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 4041000 | USD | 20180814 | Open filing evidence |
Dermatology Procedures Equipment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 3416000 | USD | 20241114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 8570000 | USD | 20241114 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 11828000 | USD | 20250328 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 3572000 | USD | 20241114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 8724000 | USD | 20241114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2794000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 5152000 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 2358000 | USD | 20230515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 13136000 | USD | 20240328 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 3566000 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 9063000 | USD | 20221109 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 3523000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1974000 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 7449000 | USD | 20220321 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 2001000 | USD | 20221109 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 1930000 | USD | 20220810 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 1148000 | USD | 20220511 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1778000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 4041000 | USD | 20211112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1234000 | USD | 20200812 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 2263000 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 1029000 | USD | 20210513 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 7873000 | USD | 20200317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 1489000 | USD | 20201110 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 4057000 | USD | 20200812 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 2171000 | USD | 20191108 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 8802000 | USD | 20200317 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 6670000 | USD | 20191118 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 2366000 | USD | 20180814 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 4334000 | USD | 20191114 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 1968000 | USD | 20191108 | Open filing evidence |
Dermatology Procedures Equipment · Operating Segments · CN
Statement Business Segments · Consolidation Items · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:CN| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 4069000 | USD | 20250328 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1102000 | USD | 20250515 | Open filing evidence |
Dermatology Procedures Equipment · Operating Segments · US
Statement Business Segments · Consolidation Items · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 141000 | USD | 20250515 | Open filing evidence |
Dermatology Procedures Equipment · Operating Segments · Geographic Distribution Other Foreign
Statement Business Segments · Consolidation Items · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 3620000 | USD | 20240328 | Open filing evidence |
Dermatology Procedures Equipment · Operating Segments · Geographic Distribution Domestic
Statement Business Segments · Consolidation Items · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 2813000 | USD | 20240328 | Open filing evidence |
Dermatology Procedures Equipment · Operating Segments · Geographic Distribution Foreign
Statement Business Segments · Consolidation Items · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 2693000 | USD | 20241114 | Open filing evidence |
Dermatology Procedures Equipment · Operating Segments · KR
Statement Business Segments · Consolidation Items · Geographic Distribution
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=country:KR| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 2828000 | USD | 20230331 | Open filing evidence |
Dermatology Procedures Equipment · Operating Segments · Geographic Distribution Domestic
Statement Business Segments · Consolidation Items · Geographic Distribution
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-09-30 | 1814000 | USD | 20231114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 547000 | USD | 20230809 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1982000 | USD | 20230331 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 1113000 | USD | 20221109 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 956000 | USD | 20220321 | Open filing evidence |
Dermatology Procedures Equipment · Operating Segments · Geographic Distribution Foreign
Statement Business Segments · Consolidation Items · Geographic Distribution
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-06-30 | 3730000 | USD | 20230809 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 2994000 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 7249000 | USD | 20231114 | Open filing evidence |
Dermatology Procedures Equipment · Geographic Distribution Other Foreign · Operating Segments
Statement Business Segments · Statement Geographical · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 391000 | USD | 20250515 | Open filing evidence |
Dermatology Procedures Equipment · Geographic Distribution Domestic · Operating Segments
Statement Business Segments · Statement Geographical · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 458000 | USD | 20240814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 598000 | USD | 20240814 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2396000 | USD | 20240328 | Open filing evidence |
Dermatology Procedures Equipment · Geographic Distribution Foreign · Operating Segments
Statement Business Segments · Statement Geographical · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-06-30 | 4556000 | USD | 20240814 | Open filing evidence |
Dermatology Procedures Equipment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-01-01 – 2017-12-31 | 8792000 | USD | 20180402 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 1751000 | USD | 20171114 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 4033000 | USD | 20170811 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 1537000 | USD | 20170515 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 7065000 | USD | 20180402 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 1550000 | USD | 20161114 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 5174000 | USD | 20161114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 1634000 | USD | 20160812 | Open filing evidence |
| 2016-01-01 – 2016-06-30 | 3624000 | USD | 20170811 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 1990000 | USD | 20160516 | Open filing evidence |
| 2015-01-01 – 2015-12-31 | 3591000 | USD | 20170313 | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 1189000 | USD | 20161114 | Open filing evidence |
| 2015-01-01 – 2015-09-30 | 1638000 | USD | 20161114 | Open filing evidence |
| 2015-04-01 – 2015-06-30 | 449000 | USD | 20160812 | Open filing evidence |
Dermatology Procedures Equipment · Geographic Distribution Domestic
Statement Business Segments · Geographic Distribution
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-07-01 – 2021-09-30 | 519000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 956000 | USD | 20210325 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 261000 | USD | 20201110 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 701000 | USD | 20201110 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 125000 | USD | 20210816 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 943000 | USD | 20201110 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 324000 | USD | 20191108 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 657000 | USD | 20191108 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 815000 | USD | 20180814 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 1193000 | USD | 20180814 | Open filing evidence |
Dermatology Procedures Equipment · Geographic Distribution Domestic · Operating Segments
Statement Business Segments · Geographic Distribution · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 879000 | USD | 20231114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 926000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2396000 | USD | 20230331 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 258000 | USD | 20220511 | Open filing evidence |
Dermatology Procedures Equipment · Geographic Distribution Foreign
Statement Business Segments · Geographic Distribution
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-09-30 | 3966000 | USD | 20211112 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 2484000 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 4725000 | USD | 20210325 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1517000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 3340000 | USD | 20211112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1109000 | USD | 20210816 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 6630000 | USD | 20210325 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 1248000 | USD | 20201110 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1508000 | USD | 20200812 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 3355000 | USD | 20200812 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 1847000 | USD | 20191108 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 6776000 | USD | 20200317 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 1970000 | USD | 20191118 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 5333000 Restated | USD | 20191118 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 2053000 | USD | 20191114 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 3364000 | USD | 20191114 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 1311000 | USD | 20191108 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 1143000 | USD | 20181114 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 3842000 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 1685000 | USD | 20180814 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 2848000 | USD | 20180814 | Open filing evidence |
Dermatology Procedures Equipment · Geographic Distribution Foreign · Operating Segments
Statement Business Segments · Geographic Distribution · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-09-30 | 6423000 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1279000 | USD | 20220511 | Open filing evidence |
Dermatology Recurring Procedures
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 21478000 | USD | 20260326 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 21171000 | USD | 20260326 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 21530000 | USD | 20250328 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 23025000 | USD | 20240328 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 22528000 | USD | 20230331 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 5710000 | USD | 20211112 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 15841000 | USD | 20211112 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 5452000 | USD | 20210816 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 10131000 | USD | 20210816 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 4679000 | USD | 20210513 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 17409000 | USD | 20220321 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 3835000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 12332000 | USD | 20211112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 2796000 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 8497000 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 5701000 | USD | 20210513 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 23713000 | USD | 20210325 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 5991000 | USD | 20201110 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 17142000 | USD | 20201110 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 5839000 | USD | 20200812 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 11151000 | USD | 20200812 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 5312000 | USD | 20200513 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 21053000 | USD | 20200317 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 5393000 Restated | USD | 20191118 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 15186000 Restated | USD | 20191118 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 5022000 Restated | USD | 20191114 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 9792000 Restated | USD | 20191114 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 4770000 Restated | USD | 20191108 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 22954000 | USD | 20191030 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 5525000 | USD | 20181114 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 17051000 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 5971000 | USD | 20180814 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 11527000 | USD | 20180814 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 0 | USD | 20160516 | Open filing evidence |
Dermatology Recurring Procedures · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 4727000 | USD | 20250515 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 15416000 | USD | 20241114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 5339000 | USD | 20240814 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 4696000 | USD | 20250515 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 21530000 | USD | 20240328 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 5280000 | USD | 20241114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5456000 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 5209000 | USD | 20240515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 23025000 | USD | 20230331 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 5847000 | USD | 20221109 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 16496000 | USD | 20221109 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 5582000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 10649000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 5067000 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 22528000 | USD | 20220321 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 5710000 | USD | 20221109 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 5452000 | USD | 20210816 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 10131000 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 17409000 | USD | 20220321 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 3835000 | USD | 20201110 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 12332000 | USD | 20201110 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 2796000 | USD | 20210816 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 23713000 | USD | 20210325 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 5991000 | USD | 20201110 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 5839000 | USD | 20191114 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 11151000 | USD | 20200812 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 5312000 | USD | 20200513 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 21053000 | USD | 20200317 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 5393000 Restated | USD | 20191118 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 15186000 Restated | USD | 20191118 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 5022000 Restated | USD | 20191114 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 9792000 Restated | USD | 20191114 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 4770000 | USD | 20191108 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 5525000 | USD | 20181114 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 11527000 | USD | 20180814 | Open filing evidence |
Dermatology Recurring Procedures · Operating Segments · Geographic Distribution Other Foreign
Statement Business Segments · Consolidation Items · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 376000 | USD | 20250515 | Open filing evidence |
Dermatology Recurring Procedures · Operating Segments · Geographic Distribution Domestic
Statement Business Segments · Consolidation Items · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 4847000 | USD | 20240515 | Open filing evidence |
Dermatology Recurring Procedures · Operating Segments · Geographic Distribution Foreign
Statement Business Segments · Consolidation Items · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-06-30 | 792000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 677000 | USD | 20240814 | Open filing evidence |
Dermatology Recurring Procedures · Operating Segments · KR
Statement Business Segments · Consolidation Items · Geographic Distribution
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=country:KR| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 941000 | USD | 20230331 | Open filing evidence |
Dermatology Recurring Procedures · Operating Segments · Geographic Distribution Other Foreign
Statement Business Segments · Consolidation Items · Geographic Distribution
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=sskn:GeographicDistributionOtherForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 372000 | USD | 20230331 | Open filing evidence |
Dermatology Recurring Procedures · Operating Segments · Geographic Distribution Domestic
Statement Business Segments · Consolidation Items · Geographic Distribution
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 4960000 | USD | 20231114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 14948000 | USD | 20231114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5141000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 21585000 | USD | 20230331 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 5527000 | USD | 20221109 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 5370000 | USD | 20221109 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 4426000 | USD | 20220511 | Open filing evidence |
Dermatology Recurring Procedures · Operating Segments · Geographic Distribution Foreign
Statement Business Segments · Consolidation Items · Geographic Distribution
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 320000 | USD | 20231114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 405000 | USD | 20230809 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 340000 | USD | 20221109 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 561000 | USD | 20220321 | Open filing evidence |
Dermatology Recurring Procedures · KR · Operating Segments
Statement Business Segments · Statement Geographical · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:StatementGeographicalAxis=country:KR;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 673000 | USD | 20240328 | Open filing evidence |
Dermatology Recurring Procedures · Geographic Distribution Foreign · Operating Segments
Statement Business Segments · Statement Geographical · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 488000 | USD | 20241114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 997000 | USD | 20241114 | Open filing evidence |
Dermatology Recurring Procedures · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 4498000 | USD | 20180515 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 6202000 | USD | 20170811 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 5731000 | USD | 20170515 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 23508000 Restated | USD | 20180402 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 6205000 | USD | 20171114 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 17826000 | USD | 20171114 | Open filing evidence |
| 2016-01-01 – 2016-06-30 | 11621000 | USD | 20170811 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 5528000 | USD | 20170515 | Open filing evidence |
| 2015-04-01 – 2015-06-30 | 104000 | USD | 20160812 | Open filing evidence |
| 2015-01-01 – 2015-03-31 | 0 | USD | 20160516 | Open filing evidence |
Dermatology Recurring Procedures · CN · Operating Segments
Statement Business Segments · Geographic Distribution · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=country:CN;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 0 | USD | 20230331 | Open filing evidence |
Dermatology Recurring Procedures · KR · Operating Segments
Statement Business Segments · Geographic Distribution · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=country:KR;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 888000 | USD | 20230331 | Open filing evidence |
Dermatology Recurring Procedures · Geographic Distribution Domestic
Statement Business Segments · Geographic Distribution
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-09-30 | 14923000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 16848000 | USD | 20210325 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 11957000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 8267000 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 5597000 | USD | 20210513 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 23645000 | USD | 20200317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 5991000 | USD | 20201110 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 17142000 | USD | 20201110 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 11151000 | USD | 20200812 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 21053000 | USD | 20200317 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 15186000 Restated | USD | 20191118 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 9792000 | USD | 20191114 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 4770000 Restated | USD | 20191108 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 17051000 | USD | 20181114 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 11527000 | USD | 20180814 | Open filing evidence |
Dermatology Recurring Procedures · Geographic Distribution Domestic · Operating Segments
Statement Business Segments · Geographic Distribution · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-06-30 | 9988000 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 4847000 | USD | 20230515 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 5527000 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 15393000 | USD | 20221109 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 4689000 | USD | 20220511 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 16848000 | USD | 20220321 | Open filing evidence |
Dermatology Recurring Procedures · Geographic Distribution Foreign
Statement Business Segments · Geographic Distribution
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-04-01 – 2021-06-30 | 325000 | USD | 20210816 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 578000 | USD | 20210816 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 253000 | USD | 20210513 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 561000 | USD | 20210325 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 145000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 375000 | USD | 20211112 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 230000 | USD | 20210816 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 68000 | USD | 20200317 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 0 | USD | 20191118 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 0 | USD | 20191114 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 0 | USD | 20191108 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 20181114 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 0 | USD | 20181114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 0 | USD | 20180814 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 0 | USD | 20180814 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 0 | USD | 20180515 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 0 | USD | 20180814 | Open filing evidence |
Dermatology Recurring Procedures · Geographic Distribution Foreign · Operating Segments
Statement Business Segments · Geographic Distribution · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 320000 | USD | 20231114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 315000 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 362000 | USD | 20230515 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1103000 | USD | 20221109 | Open filing evidence |